专题：CNS Lymphoma Diagnosis and Treatment

This cluster of papers focuses on the diagnosis, treatment, and management of primary central nervous system lymphoma (PCNSL). It covers various aspects such as prognostic scoring systems, chemotherapy and radiotherapy regimens, use of methotrexate and rituximab therapy, genetic features, neurological masquerade syndromes, and cognitive functions in PCNSL patients.
最新文献
Low Flow Cytometry Events in Detecting CNS Involvement in Pediatric BCP-ALL: NGS Validation and Prognostic Significance

article Full Text OpenAlex

Lisocabtagene maraleucel in patients with relapsed or refractory marginal zone lymphoma (TRANSCEND FL): primary analysis results from the global, multicohort, single-arm, phase 2 study

article Full Text OpenAlex

Varicella and varicella zoster virus meningoencephalitis in a diffuse large B-cell lymphoma patient after chimeric antigen receptor-T-cell therapy

article Full Text OpenAlex

Non-Neoplastic Disorders Mimicking Anterior Uveitis

article Full Text OpenAlex

Inducible Costimulator and Its Ligand Promote Proliferation and Migration of Tumor Cells in Cutaneous T-Cell Lymphoma

article Full Text OpenAlex

Intravitreal management of ocular lymphoma should use adjusted drug concentrations not fixed dosages

article Full Text OpenAlex

EBV-negative, CNS-restricted iatrogenic lymphoproliferative disorder during long-term infliximab monotherapy: interval enlargement despite cessation and steroid responsiveness

article Full Text OpenAlex

Use of Glucarpidase for Methotrexate-Induced Nephrotoxicity During the Treatment of Primary Central Nervous System Lymphoma

article Full Text OpenAlex

Advancing the classification of hematolymphoid neoplasms together: for patients, medicine, and science

article Full Text OpenAlex

Primary Orbital Extranodal Natural Killer/T-Cell Lymphoma in a Young African Male: A Case Report

article Full Text OpenAlex

近5年高被引文献
Primary central nervous system lymphoma

review Full Text OpenAlex 215 FWCI45.0273

Ravulizumab in Aquaporin‐4–Positive Neuromyelitis Optica Spectrum Disorder

article Full Text OpenAlex 167 FWCI42.616

Nivolumab+AVD in Advanced-Stage Classic Hodgkin’s Lymphoma

article Full Text OpenAlex 160 FWCI69.4518

T-Cell Lymphomas, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology

article Full Text OpenAlex 154 FWCI20.9796

Brentuximab Vedotin with Chemotherapy in Pediatric High-Risk Hodgkin’s Lymphoma

article Full Text OpenAlex 152 FWCI20.9819

Long-term efficacy, safety and neurotolerability of MATRix regimen followed by autologous transplant in primary CNS lymphoma: 7-year results of the IELSG32 randomized trial

article Full Text OpenAlex 151 FWCI17.6907

Immune checkpoint inhibitor-related hearing loss: a systematic review and analysis of individual patient data

review Full Text OpenAlex 151 FWCI39.6049

The Global Retinoblastoma Outcome Study: a prospective, cluster-based analysis of 4064 patients from 149 countries

article Full Text OpenAlex 138 FWCI26.7501

Proposed New Dynamic Prognostic Index for Diffuse Large B-Cell Lymphoma: International Metabolic Prognostic Index

article Full Text OpenAlex 137 FWCI19.9548

The genomic and transcriptional landscape of primary central nervous system lymphoma

article Full Text OpenAlex 135 FWCI15.9465